Franklin Resources’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $240K | Sell |
21,756
-5,826
| -21% | -$90K | ﹤0.01% | 2731 |
|
|
2025
Q4 | $562K | Sell |
27,582
-60,176
| -69% | -$1.06M | ﹤0.01% | 2352 |
|
|
2025
Q3 | $1.39M | Sell |
87,758
-44,543
| -34% | -$658K | ﹤0.01% | 1937 |
|
|
2025
Q2 | $1.77M | Buy |
132,301
+94,006
| +245% | +$1.27M | ﹤0.01% | 1755 |
|
|
2025
Q1 | $390K | Sell |
38,295
-250,133
| -87% | -$2.9M | ﹤0.01% | 2369 |
|
|
2024
Q4 | $4.57M | Buy |
288,428
+194
| +0.1% | +$10.1K | ﹤0.01% | 1382 |
|
|
2024
Q3 | $17.4M | Sell |
288,234
-111,980
| -28% | -$5.53M | ﹤0.01% | 934 |
|
|
2024
Q2 | $18.3M | Sell |
400,214
-231,835
| -37% | -$12.5M | 0.01% | 886 |
|
|
2024
Q1 | $41.8M | Sell |
632,049
-67,376
| -10% | -$4M | 0.01% | 635 |
|
|
2023
Q4 | $27.8M | Buy |
699,425
+226,674
| +48% | +$7.11M | 0.01% | 671 |
|
|
2023
Q3 | $15.1M | Hold |
472,751
| – | – | 0.01% | 818 |
|
|
2023
Q2 | $19M | Hold |
472,751
| – | – | 0.01% | 769 |
|
|
2023
Q1 | $20.2M | Hold |
472,751
| – | – | 0.01% | 763 |
|
|
2022
Q4 | $22.7M | Sell |
472,751
-247
| -0.1% | -$11.5K | 0.01% | 740 |
|
|
2022
Q3 | $17.8M | Buy |
472,998
+118
| +0% | +$4.09K | 0.01% | 796 |
|
|
2022
Q2 | $13.1M | Buy |
472,880
+78,203
| +20% | +$3.43M | 0.01% | 889 |
|
|
2022
Q1 | $21.5M | Sell |
394,677
-11
| -0% | -$565 | 0.01% | 838 |
|
|
2021
Q4 | $23.1M | Buy |
394,688
+28
| +0% | +$1.4K | 0.01% | 855 |
|
|
2021
Q3 | $15.6M | Sell |
394,660
-65
| -0% | -$2.31K | 0.01% | 952 |
|
|
2021
Q2 | $16.8M | Buy |
394,725
+134,546
| +52% | +$7.29M | 0.01% | 904 |
|
|
2021
Q1 | $16M | Buy |
260,179
+53
| +0% | +$3.36K | 0.01% | 885 |
|
|
2020
Q4 | $18.3M | Buy |
+260,126
| New | +$16.4M | 0.01% | 829 |
|
Other funds holding KROS
NCM
VCM
O
VPM
MAP